Research News
While COVID-19 infected patients should be treated with standard anticoagulation therapies, such as blood thinning medication, a new study by researchers at the George Washington University shows that anticoagulating patients at higher doses, without traditional medical indications to do so, may be…
Third-year MD student King John Pascual and mentor Ali Pourmand, MD, from SMHS are presenting findings at the American College of Emergency Physicians on the role of Google searches during the early phase of the pandemic in the U.S.
Moncef Slaoui, PhD, MBA, chief adviser for the COVID-19 vaccine development initiative Operation Warp Speed, visited GW on Oct. 21 to raise awareness for the national vaccine development efforts, encourage greater participation in the clinical trials and recognize GW for exceeding its enrollment…
The National Institutes of Health has awarded $1.6 million to researchers at SMHS for research on hormonal control of HIV latency.
It’s hard to recall a more important time for groundbreaking scientific research when it comes to the health and safety of the United States than in the past six months; by October the country had recorded more than 7 million cases of the novel coronavirus, and the global toll passed 1 million…
Four young researchers at the GW School of Medicine and Health Sciences were selected as fellows to the recently awarded five-year National Cancer Institute T32 Training Grant.
The retrospective study from a team at GW found that spironolactone may be safe to treat female pattern hair loss in breast cancer survivors.
Investigators at SMHS received a $1.2 million grant from Wellcome Trust to produce a controlled human hookworm infection model and establish a hookworm vaccine challenge model for two of the most advanced hookworm vaccine candidate antigens in endemic areas.
Timothy Harlan, MD, co-authored an article in The British Journal arguing for increased of "food is medicine" interventions in the health care system.
Alberto Bosque, PhD, MBA, assistant professor of microbiology, immunology, and tropical medicine, and his research team published in PLOS Pathogens finding a multiple sclerosis drug may be used to block HIV infection and reduce the latent reservoir.